Neoadjuvant Chemoimmunotherapy for NSCLC
This meta-analysis investigates the association of neoadjuvant chemoimmunotherapy with patient benefits vs neoadjuvant chemotherapy in patients with non–small cell lung cancer (NSCLC).
This meta-analysis investigates the association of neoadjuvant chemoimmunotherapy with patient benefits vs neoadjuvant chemotherapy in patients with non–small cell lung cancer (NSCLC).
The Cellular Cancer Biology Imaging Research (CCBIR) Centers are developing and testing enabling imaging technologies at the cellular and organ scales driven by specific fundamental…
Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
This cross-sectional study evaluates contemporary patterns of lipoprotein a testing among US veterans receiving care through the Veterans Health Administration.
This cohort study evaluates the prevalence of dementia diagnoses among US adults with autism spectrum disorder.
2024 Most Read Articles | Blood Advances | American Society of Hematology Top Ten Most Read Articles in 2024 Blood Advances is pleased to announce…
Sameem Abedin, MD, Medical College of Wisconsin, Milwaukee, WI, discusses a Phase I study investigating CLAG-M salvage chemotherapy and lintuzumab-Ac225, a radio-labeled antibody against CD33,…
Therapeutic options for PD-1 refractory skin cancer 3 Jan – 6PM BST | 1PM EDT | 10AM PDT Allison Betof Warner, Omid Hamid, Inderjit Mehmi…
Neoadjuvant chemotherapy’s effect on local disease management of breast cancer has a number of clinical implications, including tumor downsizing, potentially improved overall survival, and more.
This economic evaluation examines the cost-effectiveness of digital mammographic screening for breast cancer in the context of current treatment standards in Canada.
While pancreatic cancer rates are rising in people under age 50, a new survey conducted by the OSUCCC – James shows most people continue to…